Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +2636.7% | +883.1% | 2 / 3 | +16.1% | +6.45 pp | +4.98 pp | +7.8% | 0.00 | 6.75 | 63,9 | +16,1% | 3,0 | +2.636,7% | 6.75 | 106.49 | −93,7% |
| Pts | 12 | 12 | 8 | 8 | 12 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 5.500 (close price on 2026-10-06)EPS (TTM): 815,1
Financial charts
1.Revenue & growth
VND bn63,9Q3/26
1.Revenue & growth
VND bn63,9Q3/26
2.Profit & growth
VND bn3,04Q3/26
3.Profit mix (Penman)
VND bn15,4Q3/26
4.Margins & cost structure
%7.0%Q3/26
5.Returns & cash cycle
% · days9.5%Q3/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn222Q3/26
8.Funding & debt health
VND bn · times222Q3/26
9.Revenue backlog
VND bn0,00Q3/26
10.Valuation
times · %6,7×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %190Q3/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-168%
averaged over 1 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26